Europe Transcriptomics Market Outlook, 2030
Europe transcriptomics market was valued $1,479.6 million and will grow 9.9% annually over 2022-2031.
- Bonafide Trust
- 14-04-2025
- Pages : 101
- Figures : 49
- Tables : 45
- Region : South America
- Category : Lifescience & Healthcare
- Medical Devices
The Europe transcriptomics market has developed into a crucial element of the wider life sciences industry, propelled by swift progress in gene expression analysis technologies and an increased emphasis on personalized medicine. Transcriptomics, which examines the entire array of RNA transcripts generated by the genome under specific conditions or within a specific cell, offers crucial revelations about gene function, regulation, and cellular reactions. This domain has gained significant traction in recent years as scientists and healthcare professionals strive to gain insights into complex diseases like cancer, neurological disorders, and cardiovascular issues. Europe, with its strong biomedical research infrastructure, premier academic institutions, and a growing biotech landscape, has positioned itself as an essential contributor in this transformative field of genomics. The region enjoys robust governmental backing for genomics and molecular biology research, with initiatives such as Horizon Europe and the European Strategy Forum on Research Infrastructures (ESFRI) driving investment in transcriptomics projects. Additionally, partnerships among universities, pharmaceutical firms, and clinical research institutions have expedited the implementation of transcriptomics technologies in drug discovery, diagnostics, and disease modeling.
Europe transcriptomics market was valued at $1,479.6 million in 2021 and will grow by 9.9% annually over 2021-2031. The market is marked by a rising demand for next-generation sequencing (NGS) and microarray technologies, both of which are fundamental to transcriptome profiling. These instruments allow for high-throughput, accurate analysis of RNA expression, aiding in the identification of gene signatures and biomarkers vital for disease prognosis and therapeutic targeting. Innovations in bioinformatics, artificial intelligence (AI), and cloud computing have further improved the ability to manage and interpret extensive transcriptomics data, rendering the technology more accessible and significant in clinical environments. Furthermore, the increasing incidence of chronic and genetic diseases in Europe has driven the need for targeted treatment strategies, with transcriptomics being central to uncovering disease mechanisms on a molecular scale. Nations like Germany, the UK, France, and the Netherlands are at the forefront of transcriptomics research, upheld by a blend of public-private collaborations, favorable regulatory environments for innovation, and growing healthcare spending on precision medicine initiatives.
What's Inside a Bonafide Research`s industry report?
A Bonafide Research industry report provides in-depth market analysis, trends, competitive insights, and strategic recommendations to help businesses make informed decisions.
Download SampleConsidered in this report
• Historic Year: 2019
• Base year: 2024
• Estimated year: 2025
• Forecast year: 2030
Aspects covered in this report
• Europe Transcriptomics Market with its value and forecast along with its segments
• Various drivers and challenges
• On-going trends and developments
• Top profiled companies
• Strategic recommendation
Based on Component, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Instruments
• Consumables
• Software
• Services
Based on Technology, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Polymerase Chain Reaction (PCR)
• Next-Generation Sequencing
• Microarray
• In-Situ Hybridization (ISH)
• Gene Regulation Technologies
• Other Technologies
By Application, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Drug Discovery and Development
• Diagnostics
• Single Cell Analysis
• Gene Expression
• Cell Biology
• Other Applications
By End User, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Academic and Research Institutions
• Biotechnology and Biopharmaceutical Companies
• Contract Research Organizations (CROs)
• Other End Users
The approach of the report:
This report consists of a combined approach of primary as well as secondary research. Initially, secondary research was used to get an understanding of the market and listing out the companies that are present in the market. The secondary research consists of third-party sources such as press releases, annual report of companies, analyzing the government generated reports and databases. After gathering the data from secondary sources primary research was conducted by making telephonic interviews with the leading players about how the market is functioning and then conducted trade calls with dealers and distributors of the market. Post this we have started doing primary calls to consumers by equally segmenting consumers in regional aspects, tier aspects, age group, and gender. Once we have primary data with us we have started verifying the details obtained from secondary sources.
Intended audience
This report can be useful to industry consultants, manufacturers, suppliers, associations & organizations related to agriculture industry, government bodies and other stakeholders to align their market-centric strategies. In addition to marketing & presentations, it will also increase competitive knowledge about the industry.
Table of Contents
- 1 Introduction 7
- 1.1 Industry Definition and Research Scope 7
- 1.1.1 Industry Definition 7
- 1.1.2 Research Scope 9
- 1.2 Research Methodology 12
- 1.2.1 Overview of Market Research Methodology 12
- 1.2.2 Market Assumption 13
- 1.2.3 Secondary Data 13
- 1.2.4 Primary Data 13
- 1.2.5 Data Filtration and Model Design 14
- 1.2.6 Market Size/Share Estimation 15
- 1.2.7 Research Limitations 16
- 1.3 Executive Summary 17
- 2 Market Overview and Dynamics 20
- 2.1 Market Size and Forecast 20
- 2.1.1 Impact of COVID-19 on World Economy 21
- 2.1.2 Impact of COVID-19 on the Market 23
- 2.2 Major Growth Drivers 25
- 2.3 Market Restraints and Challenges 30
- 2.4 Emerging Opportunities and Market Trends 33
- 2.5 Porter’s Fiver Forces Analysis 37
- 3 Segmentation of Europe Market by Component 41
- 3.1 Market Overview by Component 41
- 3.2 Instruments 43
- 3.3 Consumables 45
- 3.4 Software 47
- 3.5 Services 49
- 4 Segmentation of Europe Market by Technology 50
- 4.1 Market Overview by Technology 50
- 4.2 Polymerase Chain Reaction (PCR) 52
- 4.3 Next-Generation Sequencing 54
- 4.4 Microarray 56
- 4.5 In-Situ Hybridization (ISH) 58
- 4.6 Gene Regulation Technologies 60
- 4.7 Other Technologies 61
- 5 Segmentation of Europe Market by Application 62
- 5.1 Market Overview by Application 62
- 5.2 Drug Discovery and Development 64
- 5.3 Diagnostics 65
- 5.4 Single Cell Analysis 66
- 5.5 Gene Expression 67
- 5.6 Cell Biology 68
- 5.7 Other Applications 69
- 6 Segmentation of Europe Market by End User 70
- 6.1 Market Overview by End User 70
- 6.2 Academic and Research Institutions 72
- 6.3 Biotechnology and Biopharmaceutical Companies 73
- 6.4 Contract Research Organizations (CROs) 74
- 6.5 Other End Users 75
- 7 European Market 2021-2031 by Country 76
- 7.1 Overview of European Market 76
- 7.2 Germany 79
- 7.3 U.K. 81
- 7.4 France 83
- 7.5 Spain 85
- 7.6 Italy 87
- 7.7 Netherlands 89
- 7.8 Rest of European Market 91
- 8 Competitive Landscape 93
- 8.1 Overview of Key Vendors 93
- 8.2 New Product Launch, Partnership, Investment, and M&A 98
- 8.3 Company Profiles 99
- 10x Genomics 99
- Agilent Technologies, Inc. 101
- ANGLE plc 102
- Becton, Dickinson and Company (BD) 103
- Bio-Rad Laboratories, Inc. 104
- BioSypder, Inc. 105
- Bio-Techne 106
- Cytiva 107
- F. Hoffmann-La Roche Ltd. 108
- Fluidigm Corporation 109
- GE Healthcare 110
- Illumina, Inc. 111
- Menarini Silicon Biosystems 112
- Merck & Co., Inc. 113
- NanoString 114
- Pacific Biosciences of California, Inc. 115
- PerkinElmer Inc. 116
- Promega Corporation 117
- Qiagen N. V. 118
- Takara Bio Inc. 119
- Thermo Fisher Scientific Inc. 120
- RELATED REPORTS 121
Table 1. Snapshot of Europe Transcriptomics Market in Balanced Perspective, 2021-2031 18
Table 2. World Economic Outlook, 2021-2031 22
Table 3. Transcriptome Databases 28
Table 4. World Personalized Medicine Market, 2021-2031, $ bn 29
Table 5. Main Product Trends and Market Opportunities in Europe Transcriptomics Market 33
Table 6. Europe Transcriptomics Market by Component, 2021-2031, $ mn 41
Table 7. Main Instrument Products from Key Vendors 44
Table 8. Main Consumable Products from Key Vendors 46
Table 9. Main Software Products from Key Vendors 48
Table 10. Europe Transcriptomics Market by Technology, 2021-2031, $ mn 50
Table 11. Main PCR-based Transcriptomics and Key Vendors 53
Table 12. Main NGS-based Transcriptomics and Key Vendors 55
Table 13. Main Microarray-based Transcriptomics and Key Vendors 57
Table 14. Main ISH-based Transcriptomics and Key Vendors 59
Table 15. Europe Transcriptomics Market by Application, 2021-2031, $ mn 62
Table 16. Europe Transcriptomics Market by End User, 2021-2031, $ mn 70
Table 17. Europe Transcriptomics Market by Country, 2021-2031, $ mn 78
Table 18. Germany Transcriptomics Market by Component, 2021-2031, $ mn 80
Table 19. Germany Transcriptomics Market by Technology, 2021-2031, $ mn 80
Table 20. Germany Transcriptomics Market by Application, 2021-2031, $ mn 80
Table 21. U.K. Transcriptomics Market by Component, 2021-2031, $ mn 82
Table 22. U.K. Transcriptomics Market by Technology, 2021-2031, $ mn 82
Table 23. U.K. Transcriptomics Market by Application, 2021-2031, $ mn 82
Table 24. France Transcriptomics Market by Component, 2021-2031, $ mn 84
Table 25. France Transcriptomics Market by Technology, 2021-2031, $ mn 84
Table 26. France Transcriptomics Market by Application, 2021-2031, $ mn 84
Table 27. Spain Transcriptomics Market by Component, 2021-2031, $ mn 86
Table 28. Spain Transcriptomics Market by Technology, 2021-2031, $ mn 86
Table 29. Spain Transcriptomics Market by Application, 2021-2031, $ mn 86
Table 30. Italy Transcriptomics Market by Component, 2021-2031, $ mn 88
Table 31. Italy Transcriptomics Market by Technology, 2021-2031, $ mn 88
Table 32. Italy Transcriptomics Market by Application, 2021-2031, $ mn 88
Table 33. Netherlands Transcriptomics Market by Component, 2021-2031, $ mn 90
Table 34. Netherlands Transcriptomics Market by Technology, 2021-2031, $ mn 90
Table 35. Netherlands Transcriptomics Market by Application, 2021-2031, $ mn 90
Table 36. Transcriptomics Market in Rest of Europe by Country, 2021-2031, $ mn 92
Table 37. Transcriptomic Products Approved by FDA 95
Table 38. Sequencing Technology Platforms for RNA-Sequencing 96
Table 39. RNA-Sequencing De Novo Assembly Software 96
Table 40. 10x Genomics: Company Snapshot 99
Table 41. 10x Genomics: Business Segmentation 100
Table 42. 10x Genomics: Product Portfolio 100
Figure 1. Research Method Flow Chart 12
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation 15
Figure 3. Europe Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2021-2031 17
Figure 4. Europe Transcriptomics Market, 2021-2031, $ mn 20
Figure 5. Impact of COVID-19 on Business 23
Figure 6. Primary Drivers and Impact Factors of Europe Transcriptomics Market 25
Figure 7. Primary Restraints and Impact Factors of Europe Transcriptomics Market 30
Figure 8. Investment Opportunity Analysis 34
Figure 9. Porter’s Fiver Forces Analysis of Europe Transcriptomics Market 37
Figure 10. Breakdown of Europe Transcriptomics Market by Component, 2021-2031, % of Revenue 42
Figure 11. Europe Addressable Market Cap in 2022-2031 by Component, Value ($ mn) and Share (%) 42
Figure 12. Europe Transcriptomics Market by Component: Instruments, 2021-2031, $ mn 43
Figure 13. Europe Transcriptomics Market by Component: Consumables, 2021-2031, $ mn 45
Figure 14. Europe Transcriptomics Market by Component: Software, 2021-2031, $ mn 47
Figure 15. Europe Transcriptomics Market by Component: Services, 2021-2031, $ mn 49
Figure 16. Breakdown of Europe Transcriptomics Market by Technology, 2021-2031, % of Sales Revenue 51
Figure 17. Europe Addressable Market Cap in 2022-2031 by Technology, Value ($ mn) and Share (%) 51
Figure 18. Europe Transcriptomics Market by Technology: Polymerase Chain Reaction (PCR), 2021-2031, $ mn 52
Figure 19. Europe Transcriptomics Market by Technology: Next-Generation Sequencing, 2021-2031, $ mn 54
Figure 20. Europe Transcriptomics Market by Technology: Microarray, 2021-2031, $ mn 56
Figure 21. Europe Transcriptomics Market by Technology: In-Situ Hybridization (ISH), 2021-2031, $ mn 58
Figure 22. Europe Transcriptomics Market by Technology: Gene Regulation Technologies, 2021-2031, $ mn 60
Figure 23. Europe Transcriptomics Market by Technology: Other Technologies, 2021-2031, $ mn 61
Figure 24. Breakdown of Europe Transcriptomics Market by Application, 2021-2031, % of Sales Revenue 63
Figure 25. Europe Addressable Market Cap in 2022-2031 by Application, Value ($ mn) and Share (%) 63
Figure 26. Europe Transcriptomics Market by Application: Drug Discovery and Development, 2021-2031, $ mn 64
Figure 27. Europe Transcriptomics Market by Application: Diagnostics, 2021-2031, $ mn 65
Figure 28. Europe Transcriptomics Market by Application: Single Cell Analysis, 2021-2031, $ mn 66
Figure 29. Europe Transcriptomics Market by Application: Gene Expression, 2021-2031, $ mn 67
Figure 30. Europe Transcriptomics Market by Application: Cell Biology, 2021-2031, $ mn 68
Figure 31. Europe Transcriptomics Market by Application: Other Applications, 2021-2031, $ mn 69
Figure 32. Breakdown of Europe Transcriptomics Market by End User, 2021-2031, % of Revenue 71
Figure 33. Europe Addressable Market Cap in 2022-2031 by End User, Value ($ mn) and Share (%) 71
Figure 34. Europe Transcriptomics Market by End User: Academic and Research Institutions, 2021-2031, $ mn 72
Figure 35. Europe Transcriptomics Market by End User: Biotechnology and Biopharmaceutical Companies, 2021-2031, $ mn 73
Figure 36. Europe Transcriptomics Market by End User: Contract Research Organizations (CROs), 2021-2031, $ mn 74
Figure 37. Europe Transcriptomics Market by End User: Other End Users, 2021-2031, $ mn 75
Figure 38. Breakdown of European Transcriptomics Market by Country, 2021 and 2031, % of Revenue 77
Figure 39. Contribution to Europe 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%) 78
Figure 40. Transcriptomics Market in Germany, 2021-2031, $ mn 79
Figure 41. Transcriptomics Market in U.K., 2021-2031, $ mn 81
Figure 42. Transcriptomics Market in France, 2021-2031, $ mn 83
Figure 43. Transcriptomics Market in Spain, 2021-2031, $ mn 85
Figure 44. Transcriptomics Market in Italy, 2021-2031, $ mn 87
Figure 45. Transcriptomics Market in Netherlands, 2021-2031, $ mn 89
Figure 46. Transcriptomics Market in Rest of Europe, 2021-2031, $ mn 91
Figure 47. Growth Stage of Europe Transcriptomics Industry over the Forecast Period 93
Related Reports
One individual can access, store, display, or archive the report in Excel format but cannot print, copy, or share it. Use is confidential and internal only. License information
One individual can access, store, display, or archive the report in PDF format but cannot print, copy, or share it. Use is confidential and internal only. License information
Up to 10 employees in one region can store, display, duplicate, and archive the report for internal use. Use is confidential and printable. License information
All employees globally can access, print, copy, and cite data externally (with attribution to Bonafide Research). License information
Safe and Secure SSL Encrypted
Quick Contacts
Want to customize this report?
We offer 10% Free Customization at the time of purchase
Get Free Customization
Trusted Partners
Budget constraints? Get in touch with us for special pricing
Request DiscountOrder Detail
- Order Placed (09 May, 2026)
- Notify To Team (09 May, 2026)
- Report updation (10 May, 2026)
- Report Quality Check (10 May, 2026)
- Report Dispatch (11 May, 2026)
- Hard Copy
Recently Viewed Products
Europe Transcriptomics Market Outlook, 2030
We are friendly and approachable, give us a call.